Zoledronic Acid Produces Combinatory Anti-Tumor Effects with Cisplatin on Mesothelioma by Increasing p53 Expression Levels

We examined anti-tumor effects of zoledronic acid (ZOL), one of the bisphosphonates agents clinically used for preventing loss of bone mass, on human mesothelioma cells bearing the wild-type p53 gene. ZOL-treated cells showed activation of caspase-3/7, -8 and -9, and increased sub-G1 phase fractions...

Descripción completa

Detalles Bibliográficos
Autores principales: Okamoto, Shinya, Jiang, Yuanyuan, Kawamura, Kiyoko, Shingyoji, Masato, Fukamachi, Toshihiko, Tada, Yuji, Takiguchi, Yuichi, Tatsumi, Koichiro, Shimada, Hideaki, Hiroshima, Kenzo, Kobayashi, Hiroshi, Tagawa, Masatoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610651/
https://www.ncbi.nlm.nih.gov/pubmed/23555949
http://dx.doi.org/10.1371/journal.pone.0060297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610651/
https://www.ncbi.nlm.nih.gov/pubmed/23555949
http://dx.doi.org/10.1371/journal.pone.0060297

Ejemplares similares